Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Prostaglandins

• Publication date

  1981-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0090-6980(81)90219-7PMID 7036228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease.

  1980cited by this paper
• Prostacyclin in central retinal vein occlusion.

  1980cited by this paper
• The next 30 years--will the progress continue?

  1980cited by this paper
• Prostacyclin and atherosclerosis.

  1980cited by this paper
• Prostacyclin therapy in peripheral arterial disease.

  1980cited by this paper
• Influence of human low density and high density lipoprotein cholesterol on the in vitro prostaglandin I2 synthetase activity.

  1980cited by this paper
• Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries.

  1980cited by this paper
• Mass-spectrometric evidence for spontaneous and angiotensin-induced generation of prostacyclin by perfused cat lungs.

  1980cited by this paper
• Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

  1980cited by this paper
• INTRAVENOUS PROSTACYCLIN FOR ISCHAEMIC ULCERS IN PERIPHERAL ARTERY DISEASE

  1980cited by this paper
• Prostacyclin for acute coronary insufficiency.

  1980cited by this paper
• Intravenous prostacyclin for ischemic ulcers in peripheral artery disease.

  1980cited by this paper
• Malondialdehyde formation in stored plasma.

  1980cited by this paper
• Prostacyclin generation in atherosclerotic arteries.

  1979cited by this paper
• Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.

  1979cited by this paper
• A spectrophotometric method for the determination of lipid hydroperoxides.

  1979cited by this paper
• Lipoproteins and the Inhibitory Effect of Human Endothelial Cells on Platelet Function

  1978cited by this paper
• Defective Fibrinolytic and Prostacyclin-Like Activity in Human Atheromatous Plaques

  1978cited by this paper
• Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes.

  1978cited by this paper
• Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits.

  1978cited by this paper
• Enzymatic conversion of prostaglandin endoperoxide H2 and arachidonic acid to prostacyclin by cultured human endothelial cells.

  1978cited by this paper
• Oxygen-mediated heterogeneity of apo-low-density lipoprotein.

  1978cited by this paper
• Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method.

  1978cited by this paper
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

  1976cited by this paper
• POLYPLOIDAL GIANT CELLS IN A LARYNGEAL BIOPSY

  1974cited by this paper
• MENINGOCOCCAL INFECTION IN LONDON

  1974cited by this paper
• Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

  1962cited by this paper

• Investigation of Malondialdehyde ( MDA ) , C-reactive protein ( CRP ) and Homocysteine in Sera of Patients with Angina Pectoris

  2019cites this paper
• Malondialdehyde And Homocysteine Levels In Patients With Psoriasis

  2012cites this paper
• MALONDIALDEHYDE AND HOM OCYSTEINE LEVELS IN PATIENTS WITH PSORIASIS

  2011cites this paper
• Discovery of the Defensive System of the Endothelium, the Lining of the Arterial Wall

  2011cites this paper
• S-5-5 Lipid Peroxidation , Vitamin E , and Cardiovascular Disease

  2010cites this paper
• Platelets and coagulation in patients with familial hypercholesterolemia (type IIa).

  2009cites this paper
• Curcumin prevents the oxidation and lipid modification of LDL and its inhibition of prostacyclin generation by endothelial cells in culture.

  2009cites this paper
• Studies on blood pressure and hypertension in children of 13 minority nationalities in China

  2008cites this paper
• Effects of LDL and HDL on morphology of and prostacyclin synthesis in cultured vascular endothelial cells

  2008cites this paper
• Lipoperoxides as an index of free radical activity in bone marrow transplant recipients

  2007cites this paper
• Prostacyclin und synthetische Analoga

  2006cites this paper
• Vitamin C or Vitamin B6 supplementation prevent the oxidative stress and decrease of prostacyclin generation in homocysteinemic rats.

  2004cites this paper
• Intensification of Free Radical Oxidation of Low-Density Lipoproteins in the Plasma of Patients with Ischemic Heart Disease Receiving beta-Hydroxy-beta-Methylglutaryl-Coenzyme A Reductase Inhibitor Cerivastatin and Inhibition of Low-Density Lipoprotein Peroxidation with Antioxidant Probucol

  2002cites this paper
• Oxidized low density lipoprotein inhibits prostacyclin generation by rat aorta in vitro: a key role of lysolecithin.

  2001cites this paper
• Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression.

  1999cites this paper
• A study on the carotid artery intima-media thickness and its association with lipid peroxidation.

  1998cites this paper
• Lipoperoxide plasma levels in patients with liver cirrhosis.

  1997cites this paper
• Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography.

  1996cites this paper
• Increased lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits.

  1995cites this paper
• The effect of lipid peroxidation and lipolysis on the ability of lipoproteins to influence thromboplastin activity.

  1995cites this paper
• Effects of nicardipine on lipid peroxidation in rabbits given 2% cholesterol diet.

  1995cites this paper
• Effects of fish oil supplementation on the changes in myocardial cyclic adenosine monophosphate, inositol 1,4,5-triphosphate and mitochondrial calcium levels during acute coronary occlusion-reperfusion in cholesterol-fed rabbits.

  1994cites this paper
• Modified lipoproteins in diabetes.

  1994cites this paper
• Nutrition, endothelial cell metabolism, and atherosclerosis.

  1994cites this paper
• Effect of plasma on the degradation of hydroperoxides of unesterified linoleic acid and copper-peroxidized LDL.

  1994cites this paper
• Modulation by dietary vitamin E and selenium of clotting whole blood thromboxane A2 and aortic prostacyclin synthesis in rats

  1993cites this paper
• Nutrition and endothelial cell integrity: implications in atherosclerosis.

  1993cites this paper
• Lipid peroxidation--a common pathogenetic mechanism?

  1992cites this paper
• Lipid peroxides in blood from patients with atherosclerosis of coronary and peripheral arteries.

  1992cites this paper
• Palm Oil Vitamin E Effects in Hypercholesterolemia

  1992cites this paper
• Modulation of the platelet thromboxane A2 and aortic prostacyclin synthesis by dietary selenium and vitamin E

  1992cites this paper
• Lipid peroxidation, vitamin E, and cardiovascular disease.

  1992cites this paper
• [Mechanisms of anti-atherogenic effect of probucol and the prospects of its clinical use].

  1991cites this paper
• Increased levels of monohydroxy metabolites of arachidonic acid and linoleic acid in LDL and aorta from atherosclerotic rabbits.

  1991cites this paper
• Longitudinal and cross-sectional studies of the relationship between 6-keto PGF1 alpha and high density lipoproteins.

  1990cites this paper
• Prostacyclin-mediated effect of high density lipoproteins as cellular cholesterol acceptors on aortic smooth muscle cells.

  1989cites this paper
• Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism.

  1989cites this paper
• [The role of lipid peroxidation in the etiology and pathogenesis of atherosclerosis (review)].

  1989cites this paper
• Streptozotocin-induced diabetes in rat. III. Antioxidant protection of vascular complications by flunarizine and aligeron.

  1989cites this paper
• Incides of lipid peroxidation in patients with hypercholesterolemia and hypertriglyceridemia.

  1989cites this paper
• Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products.

  1989cites this paper
• Studies on oxidized low density lipoproteins. Controlled oxidation and a prostaglandin artifact.

  1989cites this paper
• Lipid peroxides and atherosclerosis.

  1989cites this paper
• Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics.

  1989cites this paper
• Antioxidants and platelets.

  1989cites this paper
• Effects of plasma lipoproteins on eicosanoid metabolism by cultured vascular smooth muscle cells.

  1988cites this paper
• Oxidized low density lipoprotein stimulates prostacyclin production by adult human vascular endothelial cells.

  1988cites this paper
• Plasma fatty acid composition and lipid peroxide levels in children with paucity of interlobular bile ducts.

  1988cites this paper
• Correlation between serum lipid peroxides and the lesion size in cerebrovascular disease.

  1988cites this paper
• Suppression of vascular prostacyclin generation by jaundiced serum: relation to lipid peroxides.

  1988cites this paper
• Effects of prostaglandins on LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes.

  1988cites this paper
• Effects of selenium, vitamin E and vitamin C on human prostacyclin and thromboxane synthesis in vitro.

  1987cites this paper
• Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct.

  1987cites this paper
• Toxicity of oxidized low‐density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle

  1987cites this paper
• The effect of thermally oxidized soya bean oil on metabolism of chylomicrons. Increased uptake and degradation of oxidized chylomicrons in cultured mouse macrophages.

  1987cites this paper
• [The prostacyclin-thromboxane A2 system in ischemic heart disease].

  1987cites this paper
• Antioxidant effects of vitamin E in hyperlipoproteinemias

  1987cites this paper
• Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus.

  1987cites this paper
• Altered arachidonic acid metabolism in platelets and aortas from selenium-deficient rats

  1986cites this paper
• Eicosanoids and the coronary circulation.

  1986cites this paper
• The influence of lipoproteins (LDL and HDL) on PGI2-formation by isolated aortic preparations of rabbits.

  1986cites this paper
• A decrease in plasma factor which stimulates prostaglandin I2 synthesis in patients with acute myocardial infarction.

  1986cites this paper
• Experimental atherosclerosis and a possible generation of free radicals.

  1985cites this paper
• [Eicosanoids, vascular function and atherosclerosis].

  1985cites this paper
• [Prostaglandins in myocardial infarct].

  1985cites this paper
• Effects of pantethine on in-vitro peroxidation of low density lipoproteins.

  1985cites this paper
• [Pathogenetic importance of prostacyclin in atherosclerosis].

  1985cites this paper
• Prostacyclin, from discovery to clinical application.

  1985cites this paper
• Plasma antioxidant potency and serum copper levels in atherosclerosis.

  1985cites this paper
• 研究 急性心筋梗塞症におけるprostaglandin I 2 産生促進血漿因子の測定

  1985cites this paper
• Dietary Supplementation with Vitamin E in Hyperlipoproteinemias: Effects on Plasma Lipid Peroxides, Antioxidant Activity, Prostacyclin Generation and Platelet Aggregability

  1985cites this paper
• Oxidized low density lipoprotein can reduce the pinocytic activity in cultured human endothelial cells as measured by cellular uptake of [14C]sucrose.

  1985cites this paper
• 17 – Platelets and Ischemic Heart Disease

  1985cites this paper
• Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation

  1984cites this paper
• Dihomo-γ-Linolenic Acid in Patients with Atherosclerosis: Effects on Platelet Aggregation, Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of Prostacyclin Generation-Reply

  1984cites this paper
• The effect of lipoproteins on the synthesis of prostacyclin, von Willebrand factor and apolipoproteins A-I and A-II in cultured human endothelial cells.

  1984cites this paper
• LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts.

  1983cites this paper
• Impact of Insulin or Tolbutamide Treatment on 14C-Arachidonic Acid Conversion to Prostacyclin and/or Thromboxane in Lungs, Aortas, and Platelets of Streptozotocin-induced Diabetic Rats

  1983cites this paper
• Lipoproteins, Blood Cells and Endothelial Integrity in Atherosclerosis: What Role for Eicosanoids?

  1983cites this paper
• Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides?

  1983cites this paper
• Serum malondialdehyde-like material (MDA-LM) in acute myocardial infarction.

  1983cites this paper
• Interactions Between Lipoproteins and PGI2 Under Physiologic and Pathophysiologic Conditions

  1983cites this paper
• DRUG CONTROL OF HYPERCHOLESTEREMIA AND PLATELET FUNCTION

  1983cites this paper
• Prostaglandins and prostaglandin inhibitors in ischemic heart disease.

  1983cites this paper
• Prostacyclin: a hormone with a therapeutic potential. The Sir Henry Dale Lecture for 1981.

  1982cites this paper